DREADD agonist 21 dihydrochloride

Cat. # Quantity Price Lead time
3607-1mg 1 mg –   in stock
3607-5mg 5 mg $119 in stock
3607-10mg 10 mg $199 in stock
Found better price? Let us know and we will propose the way forward!

DREADD agonist 21 (Compound 21, C21) is a synthetic compound for selective activation of hM3Dq (excitatory) and hM4Di (inhibitory) DREADDs (Designer Receptor Exclusively Activated by Designer Drugs) derived from the human muscarinic acetylcholine M3 (hM3) receptor. It does not agonize the hM3 receptor and displays weaker binding affinities for histamine H1, serotonin 5-HT2A, 5-HT2C, and α1A-adrenergic receptors (Ki = 6, 66, 170, and 280 nM, respectively) [1].

DREADD agonist 21 is routinely used as a chemogenetic tool for remotely controlling neuronal activity. It displays excellent brain permeability and capability to activate neurons expressing hM3Dq DREADDs and inhibit activity in neurons expressing hM4Di DREADDs in vivo [2].

This product is dihydrochloride salt, a water-soluble version of DREADD agonist 21.

[1] Chen X. et al. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs. ACS Chem. Neurosci. 2015. 6(3). 476-484.

[2] Thompson K.J. et al. DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo. ACS Pharmacol. Transl. Sci. 2018. 1(1). 61-72.

General properties

Appearance: yellow-brown powder
Molecular weight: 351.28
CAS number: 2250025-92-2
Molecular formula: C17H18N4
IUPAC name: 11-(1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine dihydrochloride
Solubility: in water, DMSO
Quality control: NMR 1H and HPLC-MS (95+%)
Storage conditions: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate.
MSDS: Download
Product specifications
Your item has been added. View your cart or proceed to checkout
The count of items is incorrect.